Target
von Hippel-Lindau disease tumor suppressor
Ligand
BDBM50446138
Substrate
n/a
Meas. Tech.
ChEMBL_1459715 (CHEMBL3370433)
Kd
5300±n/a nM
Citation
 Galdeano, CGadd, MSSoares, PScaffidi, SVan Molle, IBirced, IHewitt, SDias, DMCiulli, A Structure-guided design and optimization of small molecules targeting the protein-protein interaction between the von Hippel-Lindau (VHL) E3 ubiquitin ligase and the hypoxia inducible factor (HIF) alpha subunit with in vitro nanomolar affinities. J Med Chem 57:8657-63 (2014) [PubMed]  Article 
Target
Name:
von Hippel-Lindau disease tumor suppressor
Synonyms:
Protein G7 | VHL | VHL_HUMAN | Von Hippel-Lindau disease tumor suppressor | Von Hippel-Lindau disease tumor suppressor protein (VBC) | pVHL
Type:
Protein
Mol. Mass.:
24136.87
Organism:
Homo sapiens (Human)
Description:
P40337
Residue:
213
Sequence:
MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD
  
Inhibitor
Name:
BDBM50446138
Synonyms:
CHEMBL3108881
Type:
Small organic molecule
Emp. Form.:
C21H22N4O5
Mol. Mass.:
410.4232
SMILES:
Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(cc2)-c2cnco2)on1 |r|
Structure:
Search PDB for entries with ligand similarity: